Priming immune response to cholera toxin induced by synthetic peptides
β Scribed by Chaim O. Jacob; Shoshana Grossfeld; Michael Sela; Ruth Arnon
- Book ID
- 102827471
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 646 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
β¦ Synopsis
A systematic study has been conducted of the priming effect in the immunization against cholera toxin (CT'). We demonstrate that a priming phenomenon can be ghieved by synthetic peptides of the CT B subunit: leading-(after a subsequent booster with a subimmunizing dose of the intact toxin) to an efficient anti-CT neutralizing antibody response. This effect is obtained even upon a single administration of a peptide conjugate and even by peptides that as such are not able to induce CT cross-reactive antibodies whatsoever. This effect is specific and dose dependent. A macromolecular carrier as well as an adjuvant are essential for the induction of antitoxin response. In this respect, a totally synthetic priming agent, CTP3-poly (DL-alany1)--poly(L-lysine), was adequate for an effective priming response. The specificity of the antibodies formed after the booster was mainly towards the whole CT molecule and only a small fraction of them were specific towards the peptide used for priming. The ability of synthetic peptides to prime the immune system towards a secondary stimulus with whole organism or native protein might be of general practical value, especially in endemic areas where the population is probably constantly exposed to a low level of a particular infectious agent. This exposure, which has no influence on the unprimed immune system, could serve as a booster in the case of individuals primed with an appropriate peptide, leading to a secondary immune response.
π SIMILAR VOLUMES
## Abstract This report describes model systems which show low primary __in vitro__ syngeneic cytotoxic responses to a Moloneyβinduced YAC tumor (syngeneic in A mice) and a Rauscherβinduced RBL5 tumor (syngeneic in C57BL/6 mice) and examines different approaches to overcome these defects. Two majo